Prognosis
Moderna Shot Cleared in U.S., Ready for Delivery Starting Sunday
- Shot from biotech upstart joins vaccine from drug giant Pfizer
- Historic scientific push produces two shots at breakneck pace
This article is for subscribers only.
Moderna Inc.’s Covid-19 vaccine was cleared by U.S. regulators, the second vaccine to gain emergency authorization this month as a historic mass immunization effort ramps up across the country.
The Food and Drug Administration’s decision to grant the authorization Friday for the shot’s use among adults means that two of the six vaccine candidates identified by Operation Warp Speed are now available to the public, a feat accomplished in less than one year. Shots from AstraZeneca Plc and Johnson & Johnson that have also received U.S. government support are expected to be submitted for review next year.